666

CABIO BIOTECH(WUHAN)

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪2.47 B‬CNY
‪91.52 M‬CNY
‪445.47 M‬CNY
‪83.44 M‬
Beta (1Y)
1.25

About CABIO BIOTECH(WUHAN)

CEO
De Wei Yi
Headquarters
Wuhan
Website
Founded
2004
ISIN
CNE100005X31
FIGI
BBG00D8K8T24
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production and sale of polyunsaturated fatty acids and nutrition products. Its products include arachidonic acids (ARA), docosahexaenoic acids (DHA), natural beta-carotene products, infant formula food, functional healthcare food and dietary supplements. The company was founded on September 22, 2004 and is headquartered in Wuhan, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 688089 is 14.65 CNY — it has increased by 4.12% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange CABIO BIOTECH(WUHAN) stocks are traded under the ticker 688089.
CABIO BIOTECH(WUHAN) is going to release the next earnings report on Apr 27, 2024. Keep track of upcoming events with our Earnings Calendar.
688089 stock is 5.76% volatile and has beta coefficient of 1.25. Check out the list of the most volatile stocks — is CABIO BIOTECH(WUHAN) there?
688089 earnings for the last quarter are 0.15 CNY per share, whereas the estimation was 0.22 CNY resulting in a −32.26% surprise. The estimated earnings for the next quarter are 0.19 CNY per share. See more details about CABIO BIOTECH(WUHAN) earnings.
CABIO BIOTECH(WUHAN) revenue for the last quarter amounts to ‪126.00 M‬ CNY despite the estimated figure of ‪117.00 M‬ CNY. In the next quarter revenue is expected to reach ‪121.00 M‬ CNY.
Yes, you can track CABIO BIOTECH(WUHAN) financials in yearly and quarterly reports right on TradingView.
688089 stock has risen by 10.98% compared to the previous week, the month change is a 2.52% rise, over the last year CABIO BIOTECH(WUHAN) has showed a 45.00% decrease.
688089 net income for the last quarter is ‪34.39 M‬ CNY, while the quarter before that showed ‪25.57 M‬ CNY of net income which accounts for 34.52% change. Track more CABIO BIOTECH(WUHAN) financial stats to get the full picture.
Today CABIO BIOTECH(WUHAN) has the market capitalization of ‪2.47 B‬, it has increased by 5.50% over the last week.
Yes, 688089 dividends are paid annually. The last dividend per share was 0.30 CNY. As of today, Dividend Yield (TTM)% is 1.46%. Tracking CABIO BIOTECH(WUHAN) dividends might help you take more informed decisions.
Like other stocks, 688089 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CABIO BIOTECH(WUHAN) stock right from TradingView charts — choose your broker and connect to your account.
688089 reached its all-time high on Jan 18, 2022 with the price of 49.50 CNY, and its all-time low was 9.98 CNY and was reached on Feb 6, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CABIO BIOTECH(WUHAN) technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CABIO BIOTECH(WUHAN) stock shows the sell signal. See more of CABIO BIOTECH(WUHAN) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.